Clinical Results On The Use Of Bacterin International, Inc.’S Osteosponge® For Foot And Ankle Arthrodeses Procedures Published In Orthopedics Today
3/20/2014 10:20:24 AM
BELGRADE, Mont.--(BUSINESS WIRE)--Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft materials and bioactive coatings for medical applications, announces that results utilizing OsteoSponge® bone graft for foot and ankle arthrodeses procedures has been published in the peer-reviewed journal Orthopedics. This is the second publication for Bacterin that highlights clinical outcomes of OsteoSponge® for foot and ankle fusion procedures.
Help employers find you! Check out all the jobs and post your resume.
comments powered by